News

Empowering Women: Comedy and Art Unite in Unique Showcase

Empowering Women: Comedy and Art Unite in Unique Showcase

Empowering Women Through Laughter and Art

In an exciting new venture for women aged 30 to 50, a remarkable showcase titled 'Pass The Mic For Perimenopause' is set to take the stage soon. The highly anticipated event is produced by the same team behind the critically acclaimed 'Midlife Monologues', aiming to provide a unique platform for women to express their experiences and perspectives on perimenopause. Taking place at the vibrant PURE Theatre, attendees can expect an invigorating evening of comedy, prose, and song, all designed to lighten the challenges women face during this transformative phase of life.

The Star-Studded Cast

This innovative production features a talented ensemble of performers, including NYC comedian and podcaster, Casey Balsham, and Carole Montgomery, the creator of the renowned 'Funny Women of a Certain Age'. The audience will also be entertained by award-winning author Mary Laura Philpott, best known for her books like 'Bomb Shelter' and 'I Miss You When I Blink'. The lineup boasts an impressive array of talent from Charleston, including singer-songwriter Kanika Moore and memoirist Jaclyn Michele Smith. As each artist shares their unique voice and story, the performance promises to not only entertain but also resonate deeply with the audience.

A Night of Empowerment and Awareness

'Pass The Mic For Perimenopause' is more than just a performance; it is a movement aiming to empower women through shared narratives and laughter. The event is strategically scheduled during World Menopause Awareness Month in October, highlighting the importance of this life stage for women. Kerri Devine, the founder of Hot in Charleston, expressed the show's mission: "We're taking control and turning the tables on Perimenopause, exposing the raw humor and truth women in their 30s, 40s, and 50s need now." This sentiment reflects the show's goal of creating a safe space for women to connect and share their experiences.

Collaborative Art Installations

Enhancing the experience further, a special gallery installation will accompany the showcase, curated in partnership with the Meyer Vogl Gallery and Redux Art Center. This installation launching on the same day, October 14, will feature works from established and emerging artists, each expressing the complex journey that women navigate. Art lovers and attendees alike will gain insight into the creativity and resilience that define women's experiences.

Support and Sponsors

The event has garnered support from several sponsors, including Menopause Solutions, Hotel Bennett, and Meyer Vogl Gallery, emphasizing the community's commitment to promoting women's health and empowerment. A planned livestream will also enable broader access to the performance, allowing women from across the nation to participate in this uplifting experience.

Join Us for a Memorable Evening

Tickets for this exhilarating night start at a reasonable price, ensuring accessibility for all who wish to partake in this celebration of womanhood. Whether attending in person or tuning in via the livestream, audiences can look forward to an evening filled with humor, connection, and understanding. It is an invitation to all women to reclaim their narratives with laughter and art.

Frequently Asked Questions

What is 'Pass The Mic For Perimenopause'?

'Pass The Mic For Perimenopause' is a unique showcase that combines comedy, prose, and song aimed at women experiencing perimenopause.

When is the event taking place?

The event is scheduled for a single night and will be held on October 14 at the PURE Theatre.

Who are the featured performers?

The showcase features various performers, including Casey Balsham and Carole Montgomery, among others, providing a diverse range of entertainment.

Will there be an art installation during the event?

Yes, there will be a special art installation on display at PURE Theatre featuring contemporary works that explore women's journeys.

How can I purchase tickets?

Tickets can be purchased online directly through the theatre's platform, with an emphasis on making the event accessible to all interested participants.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

AngioDynamics' NanoKnife® System Receives FDA Clearance

Updated Category News Views 191

Introduction to AngioDynamics' Innovation AngioDynamics, Inc. (NASDAQ: ANGO), a forward-thinking medical technology firm, has made significant strides in restoring healthy blood flow and enhancing cancer treatment options. Recently, the company announced its accomplishment in receiving FDA 510(k) clearance for its advanced NanoKnife System, specifically designed for...

Continue Reading
Analyst Predicts iPhone Dominance in Apple's Future Revenues

Updated Category News Views 197

Apple's Revenue Outlook and iPhone Influence A recent analysis by Needham paints a promising picture for Apple Inc (NASDAQ: AAPL) as the company prepares for fiscal year 2025. Analyst Laura Martin affirmed a buy rating for Apple, setting an impressive price target of $260. This forecast is based on a well-crafted Discounted Cash Flow (DCF) model, which includes a cash tax...

Continue Reading
Sitetracker's Record Growth and Vision for Future Success

Updated Category News Views 398

Remarkable Achievements in 2024 for Sitetracker Sitetracker has reached significant milestones marking the close of its fiscal year with outstanding growth and exciting plans for the upcoming year. As a leader in the field of asset lifecycle management, they have positioned themselves strongly in markets worldwide, focusing on providing tools for various critical...

Continue Reading
Olympus Showcases Innovative ENT Solutions at Major Meetings

Updated Category News Views 176

Olympus Highlights Cutting-Edge ENT Solutions Olympus Corporation of the Americas, a leading medical technology company committed to enhancing health and safety, will unveil its extensive ENT portfolio at upcoming annual physician meetings. Attendees will have the opportunity to see how Olympus integrates hybrid endoscopy with advanced imaging and content management...

Continue Reading
Exciting Launch of Tech Mahindra Chess League Season 3

Updated Category News Views 101

Tech Mahindra Global Chess League Season 3 Launches with Excitement The Global Chess League (GCL) has officially begun its Season 3, and excitement fills the air as six teams are set to compete in 34 matches for the coveted championship trophy. The league kicked off at Mumbai's Royal Opera House, a perfect venue for this grand event. Spectacular Opening Ceremony in Mumbai...

Continue Reading